Enhanced antigen-specific antitumor immunity with altered peptide ligands that stabilize the MHC-peptide-TCR complex - PubMed (original) (raw)
Comparative Study
Enhanced antigen-specific antitumor immunity with altered peptide ligands that stabilize the MHC-peptide-TCR complex
J E Slansky et al. Immunity. 2000 Oct.
Free article
Abstract
T cell responsiveness to an epitope is affected both by its affinity for the presenting MHC molecule and the affinity of the MHC-peptide complex for TCR. One limitation of cancer immunotherapy is that natural tumor antigens elicit relatively weak T cell responses, in part because high-affinity T cells are rendered tolerant to these antigens. We report here that amino acid substitutions in a natural MHC class I-restricted tumor antigen that increase the stability of the MHC-peptide-TCR complex are significantly more potent as tumor vaccines. The improved immunity results from enhanced in vivo expansion of T cells specific for the natural tumor epitope. These results indicate peptides that stabilize the MHC-peptide-TCR complex may provide superior antitumor immunity through enhanced stimulation of specific T cells.
Similar articles
- Antibodies directed against the MHC-I molecule H-2Dd complexed with an antigenic peptide: similarities to a T cell receptor with the same specificity.
Polakova K, Plaksin D, Chung DH, Belyakov IM, Berzofsky JA, Margulies DH. Polakova K, et al. J Immunol. 2000 Nov 15;165(10):5703-12. doi: 10.4049/jimmunol.165.10.5703. J Immunol. 2000. PMID: 11067928 - Competitive inhibition in vivo and skewing of the T cell repertoire of antigen-specific CTL priming by an anti-peptide-MHC monoclonal antibody.
Chung DH, Belyakov IM, Derby MA, Wang J, Boyd LF, Berzofsky JA, Margulies DH. Chung DH, et al. J Immunol. 2001 Jul 15;167(2):699-707. doi: 10.4049/jimmunol.167.2.699. J Immunol. 2001. PMID: 11441073 - TCR binding kinetics measured with MHC class I tetramers reveal a positive selecting peptide with relatively high affinity for TCR.
Holmberg K, Mariathasan S, Ohteki T, Ohashi PS, Gascoigne NR. Holmberg K, et al. J Immunol. 2003 Sep 1;171(5):2427-34. doi: 10.4049/jimmunol.171.5.2427. J Immunol. 2003. PMID: 12928390 - TCR affinity for p/MHC formed by tumor antigens that are self-proteins: impact on efficacy and toxicity.
Stone JD, Harris DT, Kranz DM. Stone JD, et al. Curr Opin Immunol. 2015 Apr;33:16-22. doi: 10.1016/j.coi.2015.01.003. Epub 2015 Jan 22. Curr Opin Immunol. 2015. PMID: 25618219 Free PMC article. Review. - Exploring immunological specificity using synthetic peptide combinatorial libraries.
Pinilla C, Martin R, Gran B, Appel JR, Boggiano C, Wilson DB, Houghten RA. Pinilla C, et al. Curr Opin Immunol. 1999 Apr;11(2):193-202. doi: 10.1016/s0952-7915(99)80033-8. Curr Opin Immunol. 1999. PMID: 10322159 Review.
Cited by
- Structure and Function of HLA-A*02-Restricted Hantaan Virus Cytotoxic T-Cell Epitope That Mediates Effective Protective Responses in HLA-A2.1/K(b) Transgenic Mice.
Ma Y, Cheng L, Yuan B, Zhang Y, Zhang C, Zhang Y, Tang K, Zhuang R, Chen L, Yang K, Zhang F, Jin B. Ma Y, et al. Front Immunol. 2016 Aug 8;7:298. doi: 10.3389/fimmu.2016.00298. eCollection 2016. Front Immunol. 2016. PMID: 27551282 Free PMC article. - Dexamethasone premedication suppresses vaccine-induced immune responses against cancer.
Vormehr M, Lehar S, Kranz LM, Tahtinen S, Oei Y, Javinal V, Delamarre L, Walzer KC, Diken M, Kreiter S, Mellman I, Sahin U, Schartner JM, Türeci Ö. Vormehr M, et al. Oncoimmunology. 2020 May 13;9(1):1758004. doi: 10.1080/2162402X.2020.1758004. Oncoimmunology. 2020. PMID: 32923115 Free PMC article. - Induction of CD4(+) T cell-dependent antitumor immunity by TAT-mediated tumor antigen delivery into dendritic cells.
Wang HY, Fu T, Wang G, Zeng G, Perry-Lalley DM, Yang JC, Restifo NP, Hwu P, Wang RF. Wang HY, et al. J Clin Invest. 2002 Jun;109(11):1463-70. doi: 10.1172/JCI15399. J Clin Invest. 2002. PMID: 12045260 Free PMC article. - Cancer vaccines: progress reveals new complexities.
Yu Z, Restifo NP. Yu Z, et al. J Clin Invest. 2002 Aug;110(3):289-94. doi: 10.1172/JCI16216. J Clin Invest. 2002. PMID: 12163445 Free PMC article. Review. No abstract available. - An altered peptide ligand for naïve cytotoxic T lymphocyte epitope of TRP-2(180-188) enhanced immunogenicity.
Tang Y, Lin Z, Ni B, Wei J, Han J, Wang H, Wu Y. Tang Y, et al. Cancer Immunol Immunother. 2007 Mar;56(3):319-29. doi: 10.1007/s00262-006-0195-x. Epub 2006 Aug 12. Cancer Immunol Immunother. 2007. PMID: 16906394 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials